Studies suggest that COVID-19 aggravates beta cell function to precipitate DKA in both pre-existing and newly diagnosed diabetic patients.14,15 This is possibly because of the high expression of angiotensin-converting-enzyme 2 (ACE2), the enzyme that is the entry point of SARS-CoV-2, in the pancreas, causing direct injury to the cells. Here, ACE2 is linked to COVID-19.